H.B. Fuller Company (FUL) Form 4 Filings

FULLER H B CO director Michael J. Happe received a grant of stock units as part of director compensation. On 2026-05-29, he was awarded 429.15 stock units at $64.0800 per unit, each convertible into one share of common stock on a 1-for-1 basis.

The filing shows these units will be converted into common shares upon retirement, death, disability or certain specified events under the Directors' Deferred Compensation Plan, subject to required holding periods. After this grant, Happe holds 14,874.29 stock units and 1,343 shares of common stock directly. The Form 4 does not report any open-market purchases or sales, indicating a routine, compensation-related equity award rather than discretionary trading.

FULLER H B CO director Thomas W. Handley reported a compensation grant of stock units. On 2026-05-29, he received 536.44 stock units at $64.08 per unit under the Directors' Deferred Compensation Plan.

After this grant, Handley holds 78,335.7 stock units and 1,347.1 shares of common stock directly. Each stock unit converts into one share of common stock, generally upon retirement, death, disability, or other specified events defined in the plan, subject to required holding periods.

FULLER H B CO director Daniel L. Floreness reported a new stock unit award. On May 29, 2026, he received 343.32 stock units at a reference price of $64.08 per unit. These stock units are deferred compensation that convert into common shares on a 1-for-1 basis.

After this grant, Floreness holds 30,196.12 stock units and 1,351 shares of common stock directly. The units generally convert into common stock upon retirement, death, disability, or other specified events under the Directors' Deferred Compensation Plan, and the reported amount includes units from a dividend equivalent feature.

FULLER H B CO Executive VP and CFO John J. Corkrean reported updated equity holdings, including a new grant of phantom units. On 2026-05-22, he received 218.13 phantom units tied to common stock at a reference price of $57.78 per unit as a grant or award, not an open-market trade.

Following this grant, Corkrean directly holds 59,508 shares of common stock and 34,017.27 phantom units, which convert into common stock on a 1-for-1 basis under the Key Employee Deferred Compensation Plan. He also holds multiple tranches of restricted stock units and employee stock options with exercise prices ranging from $45.05 to $77.72, providing additional potential future equity exposure.

FULLER H B CO senior vice president Heather Campe reported updated equity holdings without any open-market buys or sells. The filing shows she received a grant of 38.5600 Phantom Units at a reference price of $57.7800 per unit, increasing her Phantom Unit balance to 5,666.5500 units.

After these updates, she directly holds 24,653.0782 shares of common stock and a range of equity awards, including restricted stock units and employee stock options tied to common shares at various exercise prices and expiration dates.

FULLER H B CO Executive VP and CFO John J. Corkrean reported updated equity holdings, including a new grant of 205.77 Phantom Units tied to the company’s common stock at a reference price of $61.25 per unit. Phantom units are deferred compensation that track the value of common shares.

After this award, Corkrean directly holds 59,508 shares of common stock and 33,661.41 Phantom Units, which convert into shares of common stock on a 1-for-1 basis under the Key Employee Deferred Compensation Plan. He also continues to hold multiple vested and time-vesting stock options and restricted stock units.

FULLER H B CO senior vice president Heather Campe reported updated equity holdings. The Form 4 shows a grant of 36.37 Phantom Units at $61.25 each, increasing her phantom unit balance to 5,605.08 units, which are tied to the company’s common stock.

Campe now directly holds 24,653.0782 shares of common stock, including amounts from a dividend reinvestment plan. She also holds multiple restricted stock unit and employee stock option awards on a 1-for-1 basis into common shares, with exercise prices ranging from $51.89 to $77.72 and expirations out to 2036.

FULLER H B CO Executive VP and CFO John J. Corkrean reported updated equity holdings, including a new compensation grant. The filing shows he received an award of 200.6000 Phantom Units at $62.8300 each, increasing his Phantom Unit balance to 33455.6400 units, all tied to common stock value.

He now directly holds 59508.0000 shares of common stock. The filing also details multiple grants of restricted stock units and employee stock options on common stock with exercise prices between $45.0500 and $77.7200 and expirations between 2027 and 2036. No open-market buys or sells are reported; most entries simply update existing grants and option positions.

H.B. Fuller senior vice president Heather Campe reported updated equity holdings, including a new award of 35.4600 phantom units tied to the company’s common stock. The phantom units were credited at $62.8300 per unit and bring her total phantom unit balance to 5,568.7100 units.

The filing also shows direct ownership of 24,653.0782 shares of common stock, which includes shares acquired through a dividend reinvestment plan. Campe holds multiple grants of restricted stock units that convert into common stock on a 1-for-1 basis and vest in three annual installments.

In addition, she holds several employee stock options to buy common shares at exercise prices ranging from $51.8900 to $77.7200, with expiration dates extending out to 2036. One option grant is fully vested, while others vest over three yearly installments beginning on the dates shown.

Director Teresa J. Rasmussen Trangsrud of FULLER H B CO received a grant of 1,000 shares of Common Stock at $65.83 per share as equity compensation. Following this grant, she directly owns 3,391.433 shares of common stock.

She also holds 20,839.95 stock units that each convert into one share of common stock. According to the plan terms, these stock units are generally converted into common shares upon retirement, death, disability, or other specified events, and some units were accumulated through a dividend reinvestment plan and dividend equivalent features.

FULLER H B CO Executive VP and CFO John J. Corkrean received a grant of 197.760 Phantom Units on Common Stock, treated as a derivative award. The grant is priced at $63.73 per unit and increases his Phantom Unit balance to 33,255.040 units, which convert into common stock on a 1-for-1 basis under the Key Employee Deferred Compensation Plan.

The filing also lists existing holdings, including multiple Employee Stock Option awards and Restricted Stock Units that vest in annual installments and convert into common stock on a 1-for-1 basis. The report shows no open‑market purchases or sales, only this compensation-related acquisition and updated derivative and stock holdings.

H.B. Fuller senior vice president Heather Campe received a grant of 34.96 phantom units on common stock, recorded at $63.73 per unit. These units convert into common shares on a 1-for-1 basis under the Key Employee Deferred Compensation Plan, bringing her phantom unit balance to 5,533.25 units. The filing also lists existing employee stock options on common stock with exercise prices between $51.89 and $77.72 per share, multiple restricted stock unit awards that convert 1-for-1 into common shares, and a direct holding of 24,653.0782 common shares.

H.B. Fuller President and CEO Celeste Beeks reported an open-market purchase of 5,170 shares of common stock at $57.08 per share through a revocable trust, bringing that indirect holding to 8,670 shares as of the transaction date.

In addition to these shares, she holds a sizable package of employee stock options and restricted stock units that can convert into common stock over time, including option grants exercisable at prices between $59.81 and $77.72 per share and multiple RSU awards that settle on a 1-for-1 share basis.

FULLER H B CO executive Heather Campe, Senior Vice President of International Growth, received a compensation-related grant of 37.65 Phantom Units on March 27, 2026 at a reference value of $59.17 per unit. After this award, she holds 5,498.29 Phantom Units, which convert into common stock on a 1-for-1 basis under the company’s deferred compensation plan. The filing also lists substantial existing equity incentives, including multiple employee stock options on tens of thousands of shares at exercise prices between the low-$50s and high-$70s, several blocks of restricted stock units that vest in annual installments, and 24,653.0782 shares of common stock held directly, some accumulated through dividend reinvestment and dividend equivalent features.

H.B. Fuller’s Executive VP and CFO John J. Corkrean received a grant of 213 Phantom Units on March 27, 2026, at a reference price of $59.17 per unit. These units convert into common stock on a 1-for-1 basis under the company’s deferred compensation plan.

After this award, Corkrean holds a total of 33,057.28 Phantom Units, along with 59,508 shares of common stock held directly. He also retains multiple employee stock option grants on common stock with exercise prices ranging from $45.05 to $77.72 and expiration dates running through 2036, plus several tranches of restricted stock units that likewise convert 1-for-1 into common shares as they vest.

H.B. Fuller Executive VP and CFO John J. Corkrean received a grant of 232.280 Phantom Units on 2026-03-13, reported at a transaction price of $54.2600 per unit. These units convert into common stock on a 1-for-1 basis under the company’s deferred compensation plan.

Following this grant, his Phantom Unit balance is 32,844.280 units. He also directly holds 59,508 shares of common stock, along with multiple employee stock options and restricted stock unit awards with various exercise prices and vesting schedules.

FULLER H B CO senior vice president of international growth Heather Campe received a grant of 41.06 Phantom Units on 2026-03-13 under a compensation plan. The grant is recorded at a reference price of $54.26 per unit and converts into common stock on a 1-for-1 basis.

After this award, Campe directly holds 5,460.64 Phantom Units, 24,653.0782 shares of common stock, and multiple employee stock options and restricted stock units on common stock with exercise prices ranging from $51.89 to $77.72 and expirations between 2028 and 2036.

FULLER H B CO Executive VP and CFO John J. Corkrean reported an equity-based compensation grant. On February 27, 2026, he acquired 191.78 Phantom Units at $65.72 per unit as a grant, not an open-market purchase.

According to footnotes, these phantom units convert into common stock on a 1-for-1 basis, generally upon certain termination events or an earlier date selected under the Key Employee Deferred Compensation Plan, subject to legal holding periods. After this grant, Corkrean held 32,612 Phantom Units.

The filing also updates direct holdings of various employee stock options, restricted stock units that vest in three annual installments of 33%, 33%, and 34%, and direct common stock holdings, reflecting his overall equity-based compensation position in the company.

H.B. Fuller senior vice president Heather Campe reported an equity award and updated her equity holdings. On February 27, 2026, she acquired 33.9000 Phantom Units at a reference price of $65.7200 per unit as a grant, bringing her total Phantom Units to 5419.5800. Footnotes indicate these units convert into common stock on a 1-for-1 basis under the company’s deferred compensation plan, with dividend equivalents reinvested in additional units. The filing also lists her direct holdings of employee stock options, restricted stock units that vest over three annual installments, and 24653.0782 shares of common stock, giving a snapshot of her overall long-term incentive position.

FULLER H B CO director Teresa J. Rasmussen Trangsrud reported an acquisition of stock units under a compensation plan. On February 27, 2026, she received 1,004.2600 stock units at an assigned value of $65.7200 per unit, increasing her stock unit balance to 20,839.9500 units.

The stock units convert into an equal number of common shares on a 1-for-1 basis after retirement, death, disability, or other specified events, subject to legal holding periods. Her directly held common stock position was reported at 2,386.5580 shares, which includes shares and stock units accumulated through dividend reinvestment and dividend equivalent features of a directors' deferred compensation plan.

FULLER H B CO director Charles T. Lauber received a grant of 147.14 stock units on common stock. The units were valued at $65.72 per unit and increase his directly held stock unit balance to 10,179.79 units.

These stock units convert into shares of common stock on a 1-for-1 basis and will be converted upon retirement, death, disability or other specified events under the Directors' Deferred Compensation Plan, subject to legal holding periods. The filing also shows he directly holds 1,351 shares of common stock.

FULLER H B CO director Ruth Kimmelshue reported an award of 502.1300 stock units on February 27, 2026 at $65.7200 per unit. These stock units convert into common stock on a 1-for-1 basis under the Directors' Deferred Compensation Plan.

The units will be converted into shares of common stock upon retirement, death, disability or certain specified events, subject to required holding periods. After this award, Kimmelshue holds 33,361.8200 stock units and 1,351.0000 shares of common stock directly.

FULLER H B CO director Michael J. Happe received a grant of 418.4400 stock units on 2026-02-27 as a grant, award, or other acquisition valued at $65.7200 per unit. These stock units convert into common shares on a 1-for-1 basis upon retirement, death, disability, or other specified events under the Directors' Deferred Compensation Plan. Following this award, Happe directly holds 14385.9100 stock units and 1343.0000 common shares.

FULLER H B CO director Thomas W. Handley received a grant of 523.05 stock units on February 27, 2026, valued at $65.72 per unit. Following this award, he holds 77,480.28 stock units and 1,347.1 shares of common stock, all reported as directly owned.

The stock units convert into common shares on a 1-for-1 basis and will be delivered upon retirement, death, disability or other specified events under the Directors' Deferred Compensation Plan, including units accumulated through a dividend equivalent feature.

FULLER H B CO director Daniel L. Florness received a grant of 334.75 stock units on common stock at $65.72 per unit. After this award, he holds 29,730.4 stock units and 1,351 shares of common stock directly. The units convert into common shares on a 1-for-1 basis upon retirement, death, disability, or other specified events under the company plan.

Corkrean John J reported acquisition or exercise transactions in a Form 4 filing for FUL. The filing lists transactions totaling 183 shares at a weighted average price of $67.49 per share. Following the reported transactions, holdings were 32,305 shares.

H.B. Fuller executive Heather Campe reported an equity compensation change involving phantom units and updated holdings in company stock and awards. On 02/13/2026, she acquired 32.57 phantom units at a reference price of $67.49, bringing her total phantom unit balance to 5,366.47, which convert into common shares on a 1-for-1 basis under the company’s deferred compensation plan.

Following the reported transactions, she directly beneficially owned 24,653.0782 shares of H.B. Fuller common stock. The filing also lists multiple fully vested and time-vested employee stock options and restricted stock units with various exercise prices and vesting schedules, reflecting her broader long-term incentive package as Sr. VP, International Growth.

H.B. Fuller senior vice president Joao Magalhaes reported routine equity activity. On February 4, 2026, 519 restricted stock units converted into common shares at $63.06 per share. This increased his directly held common stock before tax withholding.

To cover taxes on the vesting, 245 common shares were withheld at $63.06, leaving him with 3,865 directly owned common shares. He also continues to hold multiple fully vested and time-vesting employee stock options and additional restricted stock units that convert 1-for-1 into common shares.

A director of H.B. Fuller Company (FUL) reported an equity award of 1,300 restricted stock units granted on January 26, 2026. These restricted stock units convert into common stock on a 1-for-1 basis at a price of $0.0000 per unit.

The filing is an amendment that corrects the vesting details. It clarifies that the entire block of 1,300 restricted stock units will vest in full on December 1, 2028. Following this transaction, the director beneficially owns 1,300 derivative securities directly.

H.B. Fuller Executive VP and CFO John J. Corkrean reported new equity-related holdings. On January 30, 2026, he acquired 3,873.33 phantom units, with a reference price of $60.10 per unit. These phantom units convert into H.B. Fuller common stock on a 1‑for‑1 basis.

The phantom units generally convert upon certain termination events or an earlier date elected under the Key Employee Deferred Compensation Plan, subject to required holding periods. Following this transaction, Corkrean beneficially owns 32,121.38 phantom units, all held directly.

He also directly holds 59,508 shares of common stock, multiple fully vested employee stock options and options vesting in three annual installments with exercise prices ranging from $45.05 to $77.72, and several tranches of restricted stock units that convert into common stock on a 1‑for‑1 basis.

H.B. Fuller executive Heather Campe reported updated equity holdings and a new award of phantom units. On January 30, 2026, she acquired 36.08 phantom units tied to H.B. Fuller common stock at a reference price of $60.10 per unit, which convert on a 1-for-1 basis into common shares under a deferred compensation plan.

Following this transaction, Campe directly holds phantom units, common stock, multiple fully vested employee stock options with exercise prices between $51.89 and $77.72, and time-vesting restricted stock units that also convert 1-for-1 into common stock. No stock sales are reported in this filing.

H.B. Fuller executive Nathan D. Weaver reported routine equity compensation activity. On 01/27/2026, 870 restricted stock units converted on a 1-for-1 basis into 870 shares of common stock at an indicated price of $59.81 per share.

According to the filing, 268 of these shares were withheld to cover taxes due on the 870 shares issued, leaving Weaver with 11,739 shares of H.B. Fuller common stock owned directly. He also holds multiple fully vested and time-vesting employee stock options, phantom units, and additional restricted stock units that are tied to future vesting or distribution conditions.

H.B. Fuller senior vice president, general counsel and corporate secretary Gregory O. Ogunsanya reported routine equity compensation activity. On January 27, 2026, 600 restricted stock units converted into the same number of common shares at a price of $59.81 per share.

Of these, 217 shares were withheld to cover taxes due on the 600 shares issued, leaving Ogunsanya with 6,270 shares of common stock held directly. The filing also lists multiple outstanding stock options, restricted stock units, and performance stock units that generally vest in three annual installments starting on the dates shown and, where applicable, convert into common stock on a 1‑for‑1 basis.

H.B. Fuller President and CEO Celeste Mastin reported equity compensation activity involving restricted stock units and common shares. On January 27, 2026, 7,933 restricted stock units vested and converted into the same number of common shares at an indicated value of $59.81 per share. To cover taxes on this issuance, 3,122 of those shares were withheld, with the balance added to her direct holdings.

After these transactions, Mastin directly owned 32,873 shares of common stock, with an additional 3,500 shares held indirectly through a revocable trust. She also continues to hold multiple employee stock options and additional restricted stock units that vest over time, reflecting a significant ongoing equity stake aligned with the company’s performance.

H.B. Fuller VP and Corporate Controller Robert J. Martsching reported routine equity transactions. On January 27, 2026, 269 restricted stock units converted into the same number of common shares at $59.81 per share. The filing shows this increased his directly held common stock before a tax withholding.

On the same date, 77 common shares were withheld to cover taxes on the vested shares, leaving 16,033.307 common shares held directly. The report also lists his existing holdings of vested employee stock options, phantom units, and additional restricted stock units that convert to common stock on a 1‑for‑1 basis, some of which vest in three annual installments.

H.B. Fuller Senior VP Malik Muhammad Shahbaz reported routine equity compensation activity. On January 27, 2026, 600 restricted stock units converted into common stock at $59.81 per share. The filing notes that 192 of the resulting shares were withheld to cover taxes due on the 600 shares issued.

After these transactions, Shahbaz directly beneficially owned 13,697 shares of common stock, which include shares acquired through a dividend reinvestment plan. He also held multiple employee stock options that are either fully vested or vest over time, and additional restricted stock units that convert into common stock on a 1‑for‑1 basis.

H.B. Fuller senior vice president Laura J. Lorenz reported equity compensation activity involving restricted stock units and common shares. On January 27, 2026, she exercised 1,020 restricted stock units and another 600 units, each converting 1-for-1 into common stock at an exercise price of $59.81 per share.

To cover taxes on these issuances, 217 and 367 common shares were withheld, leaving her with 1,036 directly held common shares. She also continues to hold employee stock options for 14,052 and 10,237 shares and 2,072 additional restricted stock units that vest in three annual installments.

H.B. Fuller Executive Vice President James J. East reported equity transactions dated 01/27/2026. He exercised 870 restricted stock units at $59.81 per share into common stock, then had 192 shares withheld to cover taxes, as noted in the footnotes.

After these transactions, East directly owned 5,858 shares of common stock and an additional 106.19 shares indirectly through a 401(k) plan. He also reported holdings of various employee stock options, phantom units, and restricted stock units that generally convert into or are exercisable for H.B. Fuller common stock on a 1-for-1 basis, subject to stated vesting schedules.

Du Xinyu reported disposition transactions in this Form 4 filing.

Sr. VP Global R&D Xinyu Du of FULLER H B CO exercised 448 restricted stock units, converting them into common stock at $59.81 per share on January 27, 2026. A related transaction reported 134 common shares delivered to the issuer to satisfy tax obligations on the shares issued.

After these transactions, Du holds 3,081 common shares, 2,734.18 restricted stock units and employee stock options covering 32,175 shares of common stock. The remaining options span exercise prices from $48.35 to $77.72 per share, with expirations between 2030 and 2036, and RSUs convert into common stock on a 1-for-1 basis under time-based vesting schedules.

H.B. Fuller Executive VP and CFO John J. Corkrean reported routine equity compensation activity. On January 27, 2026, 1,441 restricted stock units were converted into common shares at $59.81 per share, increasing his directly held common stock before tax withholding.

On the same date, 442 common shares were withheld to cover taxes on the shares issued, leaving him with 59,508 directly owned common shares. He also continues to hold various fully vested and time-vesting employee stock options, restricted stock units, and phantom units that are each tied to H.B. Fuller common stock on a 1-for-1 basis.

H.B. Fuller senior vice president Heather Campe reported routine equity compensation activity. On January 27, 2026, 634 restricted stock units converted into common stock at an exercise price of $59.81 per share. To cover taxes on these shares, 161 common shares were withheld, as noted in the footnotes.

After these transactions, Campe directly held 24,653.0782 shares of H.B. Fuller common stock. She also held various employee stock options, phantom units and additional restricted stock units that generally vest over time or are already 100% vested, all on a 1-for-1 basis into common stock under the company’s plans.

H.B. Fuller executive Nathan D. Weaver reported multiple equity compensation transactions. On January 26, 2026, he received an award of 23,187 employee stock options with an exercise price of $59.81 per share, vesting in three annual installments starting on that date.

Weaver also acquired 3,420 restricted stock units (RSUs) that convert into common stock on a 1‑for‑1 basis and vest over three annual installments beginning January 26, 2027. Separately, 555 RSUs were exercised into common shares at $60.07, and 192 shares were withheld to cover taxes, leaving 11,137 common shares held directly. The filing lists additional previously granted, fully vested stock options, phantom units, and RSUs that remain outstanding.

H.B. Fuller director Martin Celine Christine reported an equity grant of 1,300 restricted stock units (RSUs) on January 26, 2026. The RSUs have an exercise price of $0.0000 and convert into common shares on a 1-for-1 basis.

The RSUs vest in three annual installments of 33%, 33%, and 34%, beginning on January 26, 2027, and are held as direct ownership. After this grant, the director beneficially owns 1,300 derivative securities linked to H.B. Fuller common stock.

H.B. Fuller senior vice president, general counsel and corporate secretary Gregory O. Ogunsanya reported routine equity compensation activity. On January 26, 2026, he received an employee stock option for 16,863 shares of common stock with an exercise price of $59.81 per share, vesting in three annual installments.

On the same date, 506 restricted stock units vested and were converted into the same number of common shares at $60.07 per share, with 183 shares withheld for taxes. He also received a new grant of 2,487 restricted stock units that vest in three annual installments and convert into common stock on a 1‑for‑1 basis. After these transactions, he directly owned 5,887 shares of common stock, along with multiple outstanding option, RSU, and performance stock unit awards.

H.B. Fuller Company executive Laura J. Lorenz, Sr. VP, HR & Communication, reported new equity awards. On January 26, 2026 she received an employee stock option grant for 14,052 options at an exercise price of $59.81 per share, vesting in three annual installments of 33%, 33%, and 34% beginning on that date and expiring on January 26, 2036.

She was also granted 2,072 restricted stock units (RSUs) that convert into common stock on a 1-for-1 basis and vest in three annual installments on the same schedule. The filing also lists previously held awards, including 10,237 stock options and RSU balances of 1,020.01 and 1,820.56 units, which include amounts acquired through a dividend equivalent reinvestment feature. All positions are reported as directly owned.

H.B. Fuller President and CEO Mastin Celeste Beeks reported multiple equity compensation transactions in H.B. Fuller (FUL) on January 26, 2026. Beeks received an employee stock option grant for 202,009 shares of common stock at an exercise price of $59.81 per share, vesting in three annual installments beginning on the grant date.

On the same date, 5,851 restricted stock units (RSUs) were converted into an equal number of common shares, and 2,303 shares of common stock were withheld at $60.07 per share to cover taxes on those issued shares. Beeks also received a new award of 29,798 RSUs, which vest in three annual installments starting January 26, 2027.

After these transactions, Beeks directly owned 28,062 shares of common stock, with an additional 3,500 shares held indirectly through a revocable trust, alongside multiple outstanding option and RSU positions disclosed in the filing.

H.B. Fuller VP, Corporate Controller Robert J. Martsching reported new equity awards and routine tax withholding-related share activity. On January 26, 2026, he received an employee stock option grant for 6,323 shares at an exercise price of $59.81 per share and a grant of 932 restricted stock units that convert into common stock on a 1-for-1 basis. That same day, 176 restricted stock units vested and converted into common shares at $60.07, with 51 shares withheld to cover taxes. After these transactions, Martsching directly owned 15,841.307 shares of common stock, along with multiple outstanding option and unit awards that vest over time.

H.B. Fuller senior vice president Malik Muhammad Shahbaz reported equity compensation changes in H.B. Fuller common stock. On January 26, 2026, he received an employee stock option grant for 16,863 shares at an exercise price of $59.81 per share.

On the same date, 606 restricted stock units (RSUs) converted into common shares, while 215 shares were withheld to cover taxes on the 606 issued shares. He also received a new award of 2,487 RSUs, which convert into common stock on a 1‑for‑1 basis. Following these transactions, he directly owned 13,289 shares of common stock, along with multiple vested and unvested option and RSU positions.

H.B. Fuller executive Joao Magalhaes reported multiple equity compensation transactions dated January 26, 2026. He received an employee stock option grant for 12,647 shares of common stock at an exercise price of $59.81 per share, which begins vesting in three annual installments starting on that date.

Magalhaes also exercised 149 restricted stock units into common stock, with 71 shares withheld to cover taxes at $60.07 per share, leaving 3,591 common shares held directly. He additionally received 1,865 new restricted stock units that vest in three annual installments beginning January 26, 2027, and continues to hold several fully vested option awards and other option grants with future vesting and expiration dates.